{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T20:48:44Z","timestamp":1793911724304,"version":"4.8.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T00:00:00Z","timestamp":1755820800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"the National Natural Science Foundation of China-Youth Science Fund","award":["No. 82204453"],"award-info":[{"award-number":["No. 82204453"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-16737-4","type":"journal-article","created":{"date-parts":[[2025,8,22]],"date-time":"2025-08-22T09:18:59Z","timestamp":1755854339000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Functional characteristics of fresh antitumor immune interferer GDF-15 in multiple cancers"],"prefix":"10.1038","volume":"15","author":[{"given":"Min","family":"Fang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fengrui","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhu","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,22]]},"reference":[{"issue":"4","key":"16737_CR1","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.7150\/ijbs.78535","volume":"19","author":"XP Li","year":"2023","unstructured":"Li, X. P. et al. The emerging role of Super-enhancers as therapeutic targets in the digestive system tumors. Int. J. Biol. Sci. 19 (4), 1036\u20131048 (2023).","journal-title":"Int. J. Biol. Sci."},{"issue":"3","key":"16737_CR2","first-page":"229","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 74 (3), 229\u2013263 (2024).","journal-title":"CA Cancer J. Clin."},{"key":"16737_CR3","unstructured":"Pan-cancer analysis of whole genomes. Nature  578 (7793),  82\u201393. (2020)."},{"issue":"4","key":"16737_CR4","doi-asserted-by":"publisher","first-page":"463","DOI":"10.2174\/1568009623666230817102104","volume":"24","author":"Y Liu","year":"2024","unstructured":"Liu, Y. et al. mirna-383-5p functions as an Anti-oncogene in glioma through the akt\/mtor signaling pathway by targeting VEGFA. Curr. Cancer Drug Targets. 24 (4), 463\u2013475 (2024).","journal-title":"Curr. Cancer Drug Targets"},{"issue":"9","key":"16737_CR5","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1158\/1078-0432.CCR-15-2834","volume":"22","author":"CY Ock","year":"2016","unstructured":"Ock, C. Y. et al. Pan-Cancer Immunogenomic perspective on the tumor microenvironment based on PD-L1 and CD8 T-Cell infiltration. Clin. Cancer Res. 22 (9), 2261\u20132270 (2016).","journal-title":"Clin. Cancer Res."},{"issue":"21","key":"16737_CR6","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1073\/pnas.94.21.11514","volume":"94","author":"MR Bootcov","year":"1997","unstructured":"Bootcov, M. R. et al. MIC-1, a novel macrophage inhibitory cytokine, is a divergent member of the TGF-beta superfamily. Proc. Natl. Acad. Sci. U S A. 94 (21), 11514\u201311519 (1997).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"6220","key":"16737_CR7","doi-asserted-by":"publisher","first-page":"1260419","DOI":"10.1126\/science.1260419","volume":"347","author":"M Uhl\u00e9n","year":"2015","unstructured":"Uhl\u00e9n, M. et al. Proteomics. Tissue-based map of the human proteome. Science 347 (6220), 1260419 (2015).","journal-title":"Science"},{"issue":"3","key":"16737_CR8","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.cmet.2018.07.018","volume":"28","author":"VWW Tsai","year":"2018","unstructured":"Tsai, V. W. W. et al. The MIC-1\/GDF15-GFRAL pathway in energy homeostasis: implications for obesity, cachexia, and other associated diseases. Cell. Metab. 28 (3), 353\u2013368 (2018).","journal-title":"Cell. Metab."},{"issue":"22","key":"16737_CR9","doi-asserted-by":"publisher","first-page":"5122","DOI":"10.1158\/1078-0432.CCR-23-3991","volume":"30","author":"S Stacchiotti","year":"2024","unstructured":"Stacchiotti, S. et al. GDF-15 predicts epithelioid hemangioendothelioma aggressiveness and is downregulated by sirolimus through ATF4\/ATF5 suppression. Clin. Cancer Res. 30 (22), 5122\u20135137 (2024).","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"16737_CR10","doi-asserted-by":"publisher","first-page":"5564","DOI":"10.1002\/jcp.30289","volume":"236","author":"Z Hasanpour Segherlou","year":"2021","unstructured":"Hasanpour Segherlou, Z. et al. GDF-15: diagnostic, prognostic, and therapeutic significance in glioblastoma multiforme. J. Cell. Physiol. 236 (8), 5564\u20135581 (2021).","journal-title":"J. Cell. Physiol."},{"issue":"4","key":"16737_CR11","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3233\/CBM-170792","volume":"21","author":"M Vocka","year":"2018","unstructured":"Vocka, M. et al. Growth\/differentiation factor 15 (GDF-15) as new potential serum marker in patients with metastatic colorectal cancer. Cancer Biomark. 21 (4), 869\u2013874 (2018).","journal-title":"Cancer Biomark."},{"key":"16737_CR12","unstructured":"Melero, I. et al. Neutralizing GDF-15 can overcome anti-PD-1 and anti-PD-L1 resistance in solid tumours. Nature\u00a0(2024)."},{"key":"16737_CR13","doi-asserted-by":"crossref","unstructured":"Hao, Z. et al. Upregulated BAP31 links to poor prognosis and tumor immune microenvironment in breast cancer. Int. J. Mol. Sci. 26 (13),  (2025).","DOI":"10.3390\/ijms26135975"},{"key":"16737_CR14","doi-asserted-by":"crossref","unstructured":"Uhlen, M. et al. A pathology atlas of the human cancer transcriptome. Science 357 (6352),  (2017).","DOI":"10.1126\/science.aan2507"},{"issue":"5","key":"16737_CR15","doi-asserted-by":"publisher","first-page":"e238","DOI":"10.1002\/imt2.238","volume":"3","author":"D Chen","year":"2024","unstructured":"Chen, D. et al. Sangerbox 2: enhanced functionalities and update for a comprehensive clinical bioinformatics data analysis platform. Imeta 3 (5), e238 (2024).","journal-title":"Imeta"},{"issue":"D1","key":"16737_CR16","doi-asserted-by":"publisher","first-page":"D672","DOI":"10.1093\/nar\/gkae909","volume":"53","author":"M Kanehisa","year":"2025","unstructured":"Kanehisa, M. et al. KEGG: biological systems database as a model of the real world. Nucleic Acids Res. 53 (D1), D672\u2013d677 (2025).","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"16737_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28 (1), 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"16737_CR18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.canlet.2020.04.007","volume":"482","author":"J Chen","year":"2020","unstructured":"Chen, J. et al. Downregulation of the circadian rhythm regulator HLF promotes multiple-organ distant metastases in non-small cell lung cancer through PPAR\/NF-\u03bab signaling. Cancer Lett. 482, 56\u201371 (2020).","journal-title":"Cancer Lett."},{"key":"16737_CR19","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1016\/j.actbio.2022.08.024","volume":"152","author":"Y Cui","year":"2022","unstructured":"Cui, Y. et al. Reversal of epithelial-mesenchymal transition and Inhibition of tumor stemness of breast cancer cells through advanced combined chemotherapy. Acta Biomater. 152, 380\u2013392 (2022).","journal-title":"Acta Biomater."},{"issue":"9","key":"16737_CR20","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/s43018-021-00250-4","volume":"2","author":"F Chen","year":"2021","unstructured":"Chen, F. et al. Moving pan-cancer studies from basic research toward the clinic. Nat. Cancer. 2 (9), 879\u2013890 (2021).","journal-title":"Nat. Cancer"},{"issue":"8","key":"16737_CR21","doi-asserted-by":"publisher","first-page":"1397","DOI":"10.1016\/j.ccell.2023.06.009","volume":"41","author":"Y Li","year":"2023","unstructured":"Li, Y. et al. Proteogenomic data and resources for pan-cancer analysis. Cancer Cell. 41 (8), 1397\u20131406 (2023).","journal-title":"Cancer Cell."},{"key":"16737_CR22","doi-asserted-by":"publisher","first-page":"857308","DOI":"10.3389\/fimmu.2022.857308","volume":"13","author":"G Chen","year":"2022","unstructured":"Chen, G. et al. GPC2 is a potential diagnostic, immunological, and prognostic biomarker in Pan-Cancer. Front. Immunol. 13, 857308 (2022).","journal-title":"Front. Immunol."},{"key":"16737_CR23","doi-asserted-by":"crossref","unstructured":"Kannan, S., O\u2019Connor, G. M., Bakker, E. Y. Molecular mechanisms of PD-1 and PD-L1 activity on a pan-cancer basis: A bioinformatic exploratory study. Int. J. Mol. Sci.  22 (11). (2021). \u00a0","DOI":"10.3390\/ijms22115478"},{"key":"16737_CR24","doi-asserted-by":"publisher","first-page":"849592","DOI":"10.3389\/fimmu.2022.849592","volume":"13","author":"C Wei","year":"2022","unstructured":"Wei, C. et al. Pan-Cancer analysis shows that ALKBH5 is a potential prognostic and immunotherapeutic biomarker for multiple cancer types including gliomas. Front. Immunol. 13, 849592 (2022).","journal-title":"Front. Immunol."},{"issue":"10","key":"16737_CR25","doi-asserted-by":"publisher","first-page":"e41761","DOI":"10.1097\/MD.0000000000041761","volume":"104","author":"M Fang","year":"2025","unstructured":"Fang, M. et al. Diagnostic, prognostic, and immunological roles of NCAPG in pan-cancer: A bioinformatics analysis. Med. (Baltim). 104 (10), e41761 (2025).","journal-title":"Med. (Baltim)."},{"key":"16737_CR26","doi-asserted-by":"publisher","first-page":"951","DOI":"10.3389\/fimmu.2020.00951","volume":"11","author":"J Wischhusen","year":"2020","unstructured":"Wischhusen, J., Melero, I. & Fridman, W. H. Growth\/Differentiation Factor-15 (GDF-15): from biomarker to novel targetable immune checkpoint. Front. Immunol. 11, 951 (2020).","journal-title":"Front. Immunol."},{"issue":"3","key":"16737_CR27","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1097\/CAD.0000000000001434","volume":"34","author":"Y He","year":"2023","unstructured":"He, Y. et al. Growth differentiation factor 15 is required for triple-negative breast cancer cell growth and chemoresistance. Anticancer Drugs. 34 (3), 351\u2013360 (2023).","journal-title":"Anticancer Drugs"},{"issue":"4","key":"16737_CR28","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1007\/s13258-022-01328-8","volume":"45","author":"Y Liu","year":"2023","unstructured":"Liu, Y. et al. Knockdown of growth differentiation factor-15 inhibited nonsmall cell lung cancer through inactivating PTEN\/PI3K\/AKT signaling pathway. Genes Genomics. 45 (4), 507\u2013517 (2023).","journal-title":"Genes Genomics"},{"issue":"5","key":"16737_CR29","doi-asserted-by":"publisher","first-page":"1741","DOI":"10.1053\/j.gastro.2020.12.015","volume":"160","author":"Y Myojin","year":"2021","unstructured":"Myojin, Y. et al. Hepatic stellate cells in hepatocellular carcinoma promote tumor growth via growth differentiation factor 15 production. Gastroenterology 160 (5), 1741\u20131754e16 (2021).","journal-title":"Gastroenterology"},{"key":"16737_CR30","doi-asserted-by":"crossref","unstructured":"Zhang, X. et al.\u00a0 KLF4 suppresses the proliferation of Perihilar cholangiocarcinoma by negatively regulating GDF15 and phosphorylating AKT. Oncol. Rep. 50 (6).\u00a0(2023).","DOI":"10.3892\/or.2023.8659"},{"issue":"12","key":"16737_CR31","first-page":"3749","volume":"22","author":"Y Shen","year":"2018","unstructured":"Shen, Y. et al. Research on values of GDF-15 level in the diagnosis of primary liver cancer and evaluation of chemotherapeutic effect. Eur. Rev. Med. Pharmacol. Sci. 22 (12), 3749\u20133754 (2018).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"issue":"11","key":"16737_CR32","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1016\/j.prp.2015.08.004","volume":"211","author":"J Wang","year":"2015","unstructured":"Wang, J. et al. The H6D genetic variation of GDF15 is associated with genesis, progress and prognosis in colorectal cancer. Pathol. Res. Pract. 211 (11), 845\u2013850 (2015).","journal-title":"Pathol. Res. Pract."},{"issue":"1","key":"16737_CR33","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1186\/s13008-023-00103-9","volume":"18","author":"D Yang","year":"2023","unstructured":"Yang, D. et al. Downregulation of GDF15 suppresses ferroptosis and predicts unfavorable prognosis in clear cell renal cell carcinoma. Cell. Div. 18 (1), 21 (2023).","journal-title":"Cell. Div."},{"key":"16737_CR34","doi-asserted-by":"publisher","first-page":"102129","DOI":"10.1016\/j.tranon.2024.102129","volume":"50","author":"X Zhu","year":"2024","unstructured":"Zhu, X. et al. GDF15 and LCN2 for early detection and prognosis of pancreatic cancer. Transl Oncol. 50, 102129 (2024).","journal-title":"Transl Oncol."},{"issue":"5","key":"16737_CR35","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1016\/j.stem.2024.04.004","volume":"31","author":"JJ Loh","year":"2024","unstructured":"Loh, J. J. & Ma, S. Hallmarks of cancer stemness. Cell. Stem Cell. 31 (5), 617\u2013639 (2024).","journal-title":"Cell. Stem Cell."},{"issue":"1","key":"16737_CR36","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1038\/s41590-024-02054-x","volume":"26","author":"I Staicu","year":"2025","unstructured":"Staicu, I. KEAP1 maintains stemness. Nat. Immunol. 26 (1), 3 (2025).","journal-title":"Nat. Immunol."},{"issue":"Pt 1","key":"16737_CR37","doi-asserted-by":"publisher","first-page":"118998","DOI":"10.1016\/j.jep.2024.118998","volume":"338","author":"M Zhou","year":"2025","unstructured":"Zhou, M. et al. Wu Mei Wan suppresses colorectal cancer stemness by regulating Sox9 expression via JAK2\/STAT3 pathway. J. Ethnopharmacol. 338 (Pt 1), 118998 (2025).","journal-title":"J. Ethnopharmacol."},{"issue":"1","key":"16737_CR38","doi-asserted-by":"publisher","first-page":"160","DOI":"10.7150\/ijbs.101137","volume":"21","author":"Z Wei","year":"2025","unstructured":"Wei, Z. et al. DUSP3 restrains the progression and stemness property of osteosarcoma through regulating EGFR\/STAT3\/SOX2 axis. Int. J. Biol. Sci. 21 (1), 160\u2013174 (2025).","journal-title":"Int. J. Biol. Sci."},{"key":"16737_CR39","doi-asserted-by":"crossref","unstructured":"Zhao, X. et al. GDF15 contributes to radioresistance by mediating the EMT and stemness of breast cancer cells. Int. J. Mol. Sci.  23 (18).  (2022).","DOI":"10.3390\/ijms231810911"},{"issue":"1","key":"16737_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41576-024-00761-7","volume":"26","author":"X Chen","year":"2025","unstructured":"Chen, X. et al. Chromosomal instability as a driver of cancer progression. Nat. Rev. Genet. 26 (1), 31\u201346 (2025).","journal-title":"Nat. Rev. Genet."},{"issue":"11","key":"16737_CR41","first-page":"e788","volume":"5","author":"G Federica","year":"2020","unstructured":"Federica, G., Michela, C. & Giovanna, D. Targeting the DNA damage response in cancer. MedComm 5(11), e788 (2020).","journal-title":"MedComm"},{"issue":"35","key":"16737_CR42","doi-asserted-by":"publisher","first-page":"14314","DOI":"10.1073\/pnas.1306752110","volume":"110","author":"HA Galick","year":"2013","unstructured":"Galick, H. A. et al. Germ-line variant of human NTH1 DNA glycosylase induces genomic instability and cellular transformation. Proc. Natl. Acad. Sci. U S A. 110 (35), 14314\u201314319 (2013).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"issue":"1","key":"16737_CR43","doi-asserted-by":"publisher","first-page":"114344","DOI":"10.1016\/j.yexcr.2024.114344","volume":"444","author":"W Zhao","year":"2025","unstructured":"Zhao, W. et al. DDX18 influences chemotherapy sensitivity in colorectal cancer by regulating genomic stability. Exp. Cell. Res. 444 (1), 114344 (2025).","journal-title":"Exp. Cell. Res."},{"key":"16737_CR44","doi-asserted-by":"publisher","first-page":"149074","DOI":"10.1016\/j.gene.2024.149074","volume":"935","author":"Z Li","year":"2025","unstructured":"Li, Z. et al. PICH, A protein that maintains genomic stability, can promote tumor growth. Gene 935, 149074 (2025).","journal-title":"Gene"},{"issue":"1","key":"16737_CR45","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12967-022-03415-6","volume":"20","author":"S Chen","year":"2022","unstructured":"Chen, S. et al. RNA adenosine modifications related to prognosis and immune infiltration in osteosarcoma. J. Transl Med. 20 (1), 228 (2022).","journal-title":"J. Transl Med."},{"issue":"1","key":"16737_CR46","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12943-023-01879-8","volume":"22","author":"M Han","year":"2023","unstructured":"Han, M. et al. Effects of RNA methylation on tumor angiogenesis and cancer progression. Mol. Cancer. 22 (1), 198 (2023).","journal-title":"Mol. Cancer"},{"issue":"1","key":"16737_CR47","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.tibs.2024.10.009","volume":"50","author":"HJ Dyson","year":"2025","unstructured":"Dyson, H. J. & Wright, P. E. How does p53 work? Regulation by the intrinsically disordered domains. Trends Biochem. Sci. 50 (1), 9\u201317 (2025).","journal-title":"Trends Biochem. Sci."},{"issue":"6","key":"16737_CR48","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/jcb.24484","volume":"114","author":"RJ Whitson","year":"2013","unstructured":"Whitson, R. J., Lucia, M. S. & Lambert, J. R. Growth differentiation factor-15 (GDF-15) suppresses in vitro angiogenesis through a novel interaction with connective tissue growth factor (CCN2). J. Cell. Biochem. 114 (6), 1424\u20131433 (2013).","journal-title":"J. Cell. Biochem."},{"issue":"24","key":"16737_CR49","doi-asserted-by":"publisher","first-page":"7116","DOI":"10.7150\/jca.49224","volume":"11","author":"X Zheng","year":"2020","unstructured":"Zheng, X. et al. Exosomes derived from 5-fluorouracil-resistant colon cancer cells are enriched in GDF15 and can promote angiogenesis. J. Cancer. 11 (24), 7116\u20137126 (2020).","journal-title":"J. Cancer"},{"issue":"23","key":"16737_CR50","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1038\/s41388-019-0736-3","volume":"38","author":"W Wang","year":"2019","unstructured":"Wang, W. et al. Prostate cancer promotes a vicious cycle of bone metastasis progression through inducing osteocytes to secrete GDF15 that stimulates prostate cancer growth and invasion. Oncogene 38 (23), 4540\u20134559 (2019).","journal-title":"Oncogene"},{"issue":"10","key":"16737_CR51","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1038\/ni.2703","volume":"14","author":"TF Gajewski","year":"2013","unstructured":"Gajewski, T. F., Schreiber, H. & Fu, Y. X. Innate and adaptive immune cells in the tumor microenvironment. Nat. Immunol. 14 (10), 1014\u20131022 (2013).","journal-title":"Nat. Immunol."},{"issue":"3","key":"16737_CR52","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccell.2023.02.014","volume":"41","author":"C Tay","year":"2023","unstructured":"Tay, C., Tanaka, A. & Sakaguchi, S. Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy. Cancer Cell. 41 (3), 450\u2013465 (2023).","journal-title":"Cancer Cell."},{"issue":"8023","key":"16737_CR53","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-024-07752-y","volume":"632","author":"H Sultan","year":"2024","unstructured":"Sultan, H. et al. Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy. Nature 632 (8023), 182\u2013191 (2024).","journal-title":"Nature"},{"issue":"1","key":"16737_CR54","doi-asserted-by":"publisher","first-page":"4253","DOI":"10.1038\/s41467-023-39817-3","volume":"14","author":"M Haake","year":"2023","unstructured":"Haake, M. et al. Tumor-derived GDF-15 blocks LFA-1 dependent T cell recruitment and suppresses responses to anti-PD-1 treatment. Nat. Commun. 14 (1), 4253 (2023).","journal-title":"Nat. Commun."},{"issue":"10","key":"16737_CR55","doi-asserted-by":"publisher","first-page":"3796","DOI":"10.1172\/JCI91561","volume":"127","author":"NM Ratnam","year":"2017","unstructured":"Ratnam, N. M. et al. NF-\u03baB regulates GDF-15 to suppress macrophage surveillance during early tumor development. J. Clin. Invest. 127 (10), 3796\u20133809 (2017).","journal-title":"J. Clin. Invest."},{"issue":"15","key":"16737_CR56","doi-asserted-by":"publisher","first-page":"3851","DOI":"10.1158\/1078-0432.CCR-10-0705","volume":"16","author":"P Roth","year":"2010","unstructured":"Roth, P. et al. GDF-15 contributes to proliferation and immune escape of malignant gliomas. Clin. Cancer Res. 16 (15), 3851\u20133859 (2010).","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"16737_CR57","doi-asserted-by":"publisher","first-page":"e0233846","DOI":"10.1371\/journal.pone.0233846","volume":"15","author":"Y Husaini","year":"2020","unstructured":"Husaini, Y. et al. Growth differentiation factor-15 slows the growth of murine prostate cancer by stimulating tumor immunity. PLoS One. 15 (6), e0233846 (2020).","journal-title":"PLoS One"},{"issue":"4","key":"16737_CR58","first-page":"2379","volume":"41","author":"L Duan","year":"2019","unstructured":"Duan, L. et al. The role of GDF15 in bone metastasis of lung adenocarcinoma cells. Oncol. Rep. 41 (4), 2379\u20132388 (2019).","journal-title":"Oncol. Rep."},{"issue":"9","key":"16737_CR59","doi-asserted-by":"publisher","first-page":"e3036","DOI":"10.1038\/cddis.2017.434","volume":"8","author":"Y Lu","year":"2017","unstructured":"Lu, Y. et al. CDP138 Silencing inhibits TGF-\u03b2\/Smad signaling to impair radioresistance and metastasis via GDF15 in lung cancer. Cell. Death Dis. 8 (9), e3036 (2017).","journal-title":"Cell. Death Dis."},{"key":"16737_CR60","doi-asserted-by":"crossref","unstructured":"Huntington, K. E. et al. GSK-3 inhibitor Elraglusib enhances tumor-Infiltrating immune cell activation in tumor biopsies and synergizes with Anti-PD-L1 in a murine model of colorectal cancer. Int. J. Mol. Sci. 24 (13).\u00a0 (2023).","DOI":"10.3390\/ijms241310870"},{"key":"16737_CR61","doi-asserted-by":"crossref","unstructured":"Joo, M. et al. GDF15 promotes cell growth, migration, and invasion in gastric cancer by inducing STAT3 activation. Int. J. Mol. Sci. 24 (3). (2023)","DOI":"10.3390\/ijms24032925"},{"issue":"1","key":"16737_CR62","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s13046-018-0744-0","volume":"37","author":"S Li","year":"2018","unstructured":"Li, S. et al. GDF15 promotes the proliferation of cervical cancer cells by phosphorylating AKT1 and Erk1\/2 through the receptor ErbB2. J. Exp. Clin. Cancer Res. 37 (1), 80 (2018).","journal-title":"J. Exp. Clin. Cancer Res."},{"issue":"2","key":"16737_CR63","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1038\/s12276-023-00936-y","volume":"55","author":"F Zeng","year":"2023","unstructured":"Zeng, F. et al. BET inhibitors synergize with Sunitinib in melanoma through GDF15 suppression. Exp. Mol. Med. 55 (2), 364\u2013376 (2023).","journal-title":"Exp. Mol. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16737-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16737-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T12:38:01Z","timestamp":1757421481000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-16737-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,22]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["16737"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-16737-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,22]]},"assertion":[{"value":"26 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Shanghai Outdo Biochip Company had previously completed the ethical approval process with the approval numbers YB M-05-01 and YB M-05-02 for tissue microarrays, thus ensuring compliance with ethical norms and regulations.\u00a0The other data are publicly available and considered as exempt under the ethical board review of the corresponding author\u2019s institution.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}}],"article-number":"30864"}}